Romain Dustin, Hao Shengchen, Grzyb Katie, Bashaw Linda, Parikh Neehar D, Tapper Elliot B
Division of Gastroenterology and Hepatology, University of Michigan, Ann Arbor, Michigan.
Am J Gastroenterol. 2025 Jan 29;120(9):2198-2200. doi: 10.14309/ajg.0000000000003334.
Efforts to improve adherence to quality measures in cirrhosis care are encouraged by American Association for the Study of Liver Diseases (AASLD) to improve clinical outcomes.
We prospectively evaluated 2 best practice advisory (BPA) interventions to alert clinicians caring for patients with cirrhosis and acute variceal hemorrhage or spontaneous bacterial peritonitis.
Our BPAs increased utilization. Ceftriaxone use was associated with adverse outcomes such as more blood product and broad-spectrum antibiotic use. The albumin BPA was associated with reduced mortality.
BPAs should be used with care and are best in settings with low baseline utilization of quality indicators.
美国肝病研究协会（AASLD）鼓励采取措施提高肝硬化护理质量指标的依从性，以改善临床结局。
我们前瞻性评估了2种最佳实践建议（BPA）干预措施，以提醒照顾肝硬化合并急性静脉曲张出血或自发性细菌性腹膜炎患者的临床医生。
我们的BPA提高了利用率。头孢曲松的使用与更多血液制品和广谱抗生素使用等不良结局相关。白蛋白BPA与死亡率降低相关。
BPA的使用应谨慎，在质量指标基线利用率较低的环境中使用效果最佳。
